Saudi king to undergo tests due to high fever, state news agency says

G. Samdani Avatar

·

·







Saudi king to undergo tests due to high fever, state news agency says

















XM does not provide services to residents of the United States of America.

Reuters

Saudi king to undergo tests due to high fever, state news agency says



UPDATE 1-Saudi king to undergo tests due to high fever, state news agency says

Adds details, background throughout

DUBAI, May 19 (Reuters)Saudi Arabia’s King Salman bin Abdulaziz will undergo medical tests on Sunday due to “high temperature and joint pain”, state news agency SPA reported.

The examinations will be conducted at the royal clinics at Al Salam Palace in Jeddah. The king, 88, was last admitted to hospital in April for a routine checkup, state TV reported then.

King Salman, the custodian of Islam’s holiest sites, became ruler of the world’s top oil exporter in 2015 after spending more than 2 1/2 years as the crown prince and deputy premier.

Reporting by Jana Choukeir; Editing by William Mallard

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.


Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.




Source link

Leave a Reply

Your email address will not be published. Required fields are marked *